Cidara Therapeutics (CDTX)
(Delayed Data from NSDQ)
$10.61 USD
+0.09 (0.86%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $10.67 +0.06 (0.57%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -5.22 |
EPS Last Quarter | -2.05 |
Last EPS Surprise | 47.97% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -30.67 |
Next Year | -12.36 |
EPS (TTM) | -6.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 1.28M | NA |
# of Estimates | NA | NA | 1 | NA |
High Estimate | NA | NA | 1.28M | NA |
Low Estimate | NA | NA | 1.28M | NA |
Year ago Sales | 12.72M | 17.58M | 63.90M | 1.28M |
Year over Year Growth Est. | NA | NA | -98.00% | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -5.22 | -5.51 | -30.67 | -12.36 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -5.22 | -5.51 | -30.67 | -12.36 |
High Estimate | -5.22 | -5.51 | -30.67 | -12.36 |
Low Estimate | -5.22 | -5.51 | -30.67 | -12.36 |
Year ago EPS | -1.80 | -0.80 | -5.20 | -30.67 |
Year over Year Growth Est. | -190.00% | -588.75% | -489.81% | 59.70% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -5.22 | -5.51 | -30.67 | -12.36 |
7 Days Ago | -5.22 | -5.51 | -30.67 | -12.36 |
30 Days Ago | -5.22 | -5.51 | -30.67 | -12.36 |
60 Days Ago | -3.79 | -3.29 | -13.07 | 12.63 |
90 Days Ago | -3.79 | -3.29 | -13.07 | 12.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -5.22 | -5.51 | -30.67 | -12.36 |
Zacks Consensus Estimate | -5.22 | -5.51 | -30.67 | -12.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.05 | -2.28 | -0.80 | -1.80 | NA |
Estimate | -3.94 | -1.50 | NA | -2.80 | NA |
Difference | 1.89 | -0.78 | NA | 1.00 | 0.70 |
Surprise | 47.97% | -52.00% | NA | 35.71% | 10.56% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more